Clover Biopharmaceuticals, Ltd. (2197.HK)
HKD 0.2
(4.81%)
HKD 0.2
(4.81%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 24.24 Million CNY | 105.1% |
| 2022 | -475.64 Million CNY | -617.77% |
| 2021 | -66.26 Million CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -5.12 Million CNY | 97.65% |
| 2024 Q2 | -5.12 Million CNY | 0.0% |
| 2023 FY | 24.24 Million CNY | 105.1% |
| 2023 Q2 | -618.32 Million CNY | 0.0% |
| 2023 Q1 | -618.32 Million CNY | -155.99% |
| 2023 Q4 | -218.25 Million CNY | 0.0% |
| 2023 Q3 | -218.25 Million CNY | 64.7% |
| 2022 Q2 | 3.72 Million CNY | 0.0% |
| 2022 Q1 | 3.72 Million CNY | 111.23% |
| 2022 FY | -475.64 Million CNY | -617.77% |
| 2022 Q4 | -241.54 Million CNY | 0.0% |
| 2022 Q3 | -241.54 Million CNY | -6591.33% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 FY | -66.26 Million CNY | 0.0% |
| 2021 Q4 | -33.13 Million CNY | 0.0% |
| 2021 Q3 | -33.13 Million CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 93.829% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 97.442% |